Heidelberg Pharma AG (ETR:HPHA)

Germany · Delayed Price · Currency is EUR

2.730

-0.100 (-3.53%)

May 8, 2026, 5:35 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018	Nov '17 Nov 30, 2017	Nov '16 Nov 30, 2016
Biotechnology (Startups)	1.46M	6.85M	9.86M	18.51M	2.03M
Biotechnology (Startups) Growth	-78.72%	-30.53%	-46.75%	810.30%	-76.53%
Total	1.46M	6.85M	9.86M	18.51M	2.03M
Total Growth	-78.72%	-30.53%	-46.75%	810.30%	-76.53%

Revenue by Geography

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018	Nov '17 Nov 30, 2017	Nov '16 Nov 30, 2016
Germany	5.00K	34.00K	60.00K	549.00K	477.00K
Germany Growth	-85.29%	-43.33%	-89.07%	15.09%	9.91%
USA	285.00K	2.14M	4.67M	8.98M	1.12M
USA Growth	-86.71%	-54.11%	-47.98%	700.53%	-85.54%
China	1.17M	4.67M	4.74M	8.20M	-
China Growth	-74.99%	-1.46%	-42.22%	-	-
Switzerland	-	-	145.00K	52.00K	38.00K
Switzerland Growth	-	-	178.85%	36.84%	-49.33%
Rest of The World (Excluding China)	-	-	242.00K	727.00K	113.00K
Rest of The World (Excluding China) Growth	-	-	-66.71%	543.36%	-
Total	1.46M	6.85M	9.86M	18.51M	1.75M
Total Growth	-78.71%	-30.53%	-46.75%	957.94%	-79.38%

Source: S&P Global Market Intelligence.